Clinical trials: Hepatitis D, Chronic
- Condition Hepatitis D, Chronic
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Chronic Hepatitis D Infection
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)
This is an international, multicenter, randomized, controlled, open-label Phase III trial. It will evaluate the efficacy and safety of libevitug in participants with chronic HDV infection.
- Trial name
- NCT07499544
- Testing
- Libevitug 20 mg/kg, Libevitug 10 mg/kg, Delayed treatment with libevitug
- Where
- 7 sites in United States, China and 1 more
- Volunteers
- 160 people
- Sponsor
- Huahui Health
Autoimmune Hepatitis
Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis
This is a multicentre, multinational clinical study. It comprised two consecutive segments (A and B). Segment A was designed as a randomized, double-blind, double-dummy, active-controlled, two-arm parallel-group study.
- Trial name
- NCT00838214
- Testing
- budesonide, prednisone
- Where
- Germany
- Volunteers
- 208 people
- Sponsor
- Dr. Falk Pharma GmbH